. . . . . . . . . "17"^^ . . . . . "6"^^ . . . . . "Efficacy and Safety of SPD503 in Combination With Psychostimulants"@en . . . "ensayu cl\u00EDnicu"@ast . . . "2008-09-01T00:00:00Z"^^ . . "Efficacy and Safety of SPD503 in Combination With Psychostimulants"@en . "clinical trial"@en . . "klinisch onderzoek"@nl . . . . "NCT00734578" . . . "461"^^ . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose Optimization Study Evaluating the Efficacy and Safety of SPD503 in Combination With Psychostimulants in Children and Adolescents Aged 6-17 Years With a Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)"@en . . . "Efficacy and Safety of SPD503 in Combination With Psychostimulants"@en . . . "2009-12-01T00:00:00Z"^^ . . .